ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00887107
Recruitment Status : Completed
First Posted : April 23, 2009
Last Update Posted : April 23, 2009
Sponsor:
Information provided by:
Leiden University Medical Center